Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients (Q79548134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Emin Yildirim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ugur Berberoglu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

published in

World Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

276-289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219275%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00268-006-0487-5

24 December 2019

exact match

0 references

cites work

Incidence of breast carcinoma-related lymphedema

1 reference

12 December 2020

Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer.

1 reference

12 December 2020

Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation

1 reference

12 December 2020

Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis

1 reference

12 December 2020

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

12 December 2020

Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Bre

1 reference

12 December 2020

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

12 December 2020

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

1 reference

12 December 2020

Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors

1 reference

12 December 2020

Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival

1 reference

12 December 2020

Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG)

1 reference

12 December 2020

Guidelines to assure quality in breast cancer surgery

1 reference

12 December 2020

Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group

1 reference

12 December 2020

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

12 December 2020

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

1 reference

12 December 2020

Axillary Lymph Node Status, But Not Tumor Size, Predicts Locoregional Recurrence and Overall Survival After Mastectomy for Breast Cancer

1 reference

12 December 2020

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.

1 reference

12 December 2020

Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy

1 reference

12 December 2020

Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients

1 reference

12 December 2020

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

1 reference

12 December 2020

Prognostic and predictive factors in breast cancer

1 reference

12 December 2020

Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis

1 reference

12 December 2020

A contemporary view of axillary dissection

1 reference

12 December 2020

Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.

1 reference

12 December 2020

The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes

1 reference

12 December 2020

Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer

1 reference

12 December 2020

Morbidity associated with axillary surgery for breast cancer

1 reference

12 December 2020

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence

1 reference

12 December 2020

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

12 December 2020

Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients

1 reference

12 December 2020

Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.

1 reference

12 December 2020

Index for rating diagnostic tests

1 reference

12 December 2020

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

12 December 2020

Lymph-node dissection in breast cancer

1 reference

12 December 2020

Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status

1 reference

12 December 2020

Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up

1 reference

12 December 2020

Does radical surgery to the axilla give a survival advantage in more severe breast cancer?

1 reference

12 December 2020

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

12 December 2020

The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy

1 reference

12 December 2020

Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer

1 reference

12 December 2020

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

12 December 2020

Ratios of involved nodes in early breast cancer.

1 reference

12 December 2020

Role of increased arterial inflow in arm edema after modified radical mastectomy

1 reference

12 December 2020

Axillary surgery: is it necessary?

1 reference

12 December 2020

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

1 reference

12 December 2020

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Axillary lymph node involvement in stage III breast cancer: treatment implications

1 reference

12 December 2020

Axillary surgery in breast cancer management--background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures

1 reference

12 December 2020

Axillary lymphadenectomy: a diagnostic and therapeutic procedure

1 reference

12 December 2020

Effect of axillary lymphadenectomy on breast carcinoma survival

1 reference

12 December 2020

Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct?

1 reference

12 December 2020

Consensus Statement on postmastectomy radiation therapy

1 reference

12 December 2020

Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer

1 reference

12 December 2020

The lymph node ratio as prognostic factor in node-positive breast cancer

1 reference

12 December 2020

Axillary dissection in breast cancer

1 reference

12 December 2020

Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer

1 reference

12 December 2020

Nodal treatment for patients with early stage breast cancer: guilty or innocent?

1 reference

12 December 2020

Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer

1 reference

12 December 2020

Axillary lymph node dissection in breast cancer--current status and controversies, alternative strategies and future perspectives

1 reference

12 December 2020

The use of radiotherapy after mastectomy: a review of the literature

1 reference

12 December 2020

Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?

1 reference

12 December 2020

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

12 December 2020

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

12 December 2020

Quality control in the locoregional treatment of breast cancer

1 reference

12 December 2020

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation

1 reference

12 December 2020

Axillary surgery: clinical judgment required

1 reference

12 December 2020

Predictive accuracy and explained variation

1 reference

12 December 2020

Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

1 reference

12 December 2020

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

12 December 2020

Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer

1 reference

12 December 2020

Postmastectomy radiation therapy: who needs it?

1 reference

12 December 2020

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Increased mortality from breast cancer and inadequate axillary treatment

1 reference

12 December 2020

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

1 reference

12 December 2020

Total axillary lymphadenectomy in the management of breast cancer

1 reference

12 December 2020

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

12 December 2020

Axillary dissection in the context of the biology of lymph node metastases

1 reference

12 December 2020

Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer

1 reference

12 December 2020